Stoxline.com

Stock Symbol:   

Stoxline Mobile
Home  |  Stock Charts  |  Showcases  |  Stock Ranks  |  Options  |  ETFs  |  Educations  |  Forex Crypto

Afya Limited (AFYA)

10.561   0.601 (6.03%) 03-24 12:42
Open: 11.19 Pre. Close: 9.96
High: 11.19 Low: 10.13
Volume: 343,688 Market Cap: 950(M)

Technical analysis

as of: 2023-03-24 11:58:49 AM
Overall:       
Stoxline posted a NEUTRAL today, upgraded from lower rating. Current trend continues, but could change at anytime. It is not a good time to buy or sell.
Target: Six months: 14.04     One year: 15.74
Support: Support1: 9.65    Support2: 8.03
Resistance: Resistance1: 12.02    Resistance2: 13.47
Pivot: 11.21
Moving Average: MA(5): 10.58     MA(20): 11.3
MA(100): 14.18     MA(250): 13.08
MACD: MACD(12,26): -0.8     Signal(9): -0.8
Stochastic oscillator: %K(14,3): 18.2     %D(3): 16.9
RSI: RSI(14): 35.5
52-week: High: 17.02  Low: 8.72
Average Vol(K): 3-Month: 279 (K)  10-Days: 259 (K)

Price, moving averages and Bollinger Bands

Price has closed below its short-term moving average. Short-term moving average is currently below mid-term; and below long-term moving average. From the relationship between price and moving averages: This stock is BEARISH in short-term; and BEARISH in mid-long term.
[ AFYA ] has closed above bottom band by 25.8%. Bollinger Bands are 9.2% wider than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.

Stock Price Prediction

Update at 5:00pm EST
If tomorrow: Open lower Open higher
High: 10.75 - 10.82 10.82 - 10.88
Low: 9.53 - 9.6 9.6 - 9.65
Close: 9.86 - 9.97 9.97 - 10.06

Company Description

Afya Limited, through its subsidiaries, operates as a medical education group in Brazil. It offers educational products and services, including medical schools, medical residency preparatory courses, graduate courses, and other programs to lifelong medical learners enrolled across its distribution network, as well as to third-party medical schools. The company also provides digital health services, such as subscription-based mobile app and website portal that focuses on assisting health professionals and students with clinical decision-making through tools, such as medical calculators, charts, and updated content, as well as prescriptions, clinical scores, medical procedures and laboratory exams, and others. It offers health sciences courses, which comprise medicine, dentistry, nursing, radiology, psychology, pharmacy, physical education, physiotherapy, nutrition, and biomedicine; and degree programs and courses in other subjects and disciplines, including undergraduate and post graduate courses in business administration, accounting, law, civil engineering, industrial engineering, and pedagogy. In addition, the company provides medical postgraduate specialization programs; printed and digital content; and an online medical education platform and practical medical training services. As of December 31, 2021, it operated a network of 46 undergraduate and graduate medical school campuses consisted of 30 undergrad operating units and five approved units; and a network of 2,731 medical school seats that consisted of 2,481 operating seats and 278 approved seats. The company was founded in 1999 and is headquartered in Nova Lima, Brazil.

Headline News

Fri, 24 Mar 2023
Afya Limited Announces a New Rule 10b5-1 Share Repurchase ... - Business Wire

Thu, 23 Mar 2023
Consumer Defensive Stocks on the Move Thursday: APEI, GOTU, GSUN, BRBR, EDBL, BRFS, AFYA, RAD - InvestorsObserver

Thu, 23 Mar 2023
Is Afya Ltd (AFYA) Stock Over or Undervalued? - InvestorsObserver

Thu, 23 Mar 2023
AI storytelling startup Tome records fast user growth, to launch paid tier soon - Yahoo Finance

Wed, 22 Mar 2023
After-Hours Earnings Report for March 22, 2023 : CHWY, KBH, WOR ... - Nasdaq

Thu, 16 Mar 2023
UPDATE 2-India's financial crime agency searches Franklin Templeton execs-sources - Yahoo Finance

Financial Analysis

Price to Book Value: Outperform
P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly.
Price to Earnings: Outperform
PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS).
Discounted cash flow: Outperform
DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows.
Return on Assets: Neutral
ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit.
Return on Equity: Neutral
ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency.
Debt to Equity: Outperform
evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn.
Free Technical Analysis Charts

Stock Basics & Statistics

Exchange:  NASDAQ
Sector:  Consumer Defensive
Industry:  Education & Training Services
Shares Out. 44 (M)
Shares Float 22 (M)
% Held by Insiders 40.9 (%)
% Held by Institutions 42.6 (%)
Shares Short 331 (K)
Shares Short P.Month 325 (K)

Stock Financials

EPS 0.7
EPS Est Next Qtl 0
EPS Est This Year 0
EPS Est Next Year 0
Book Value (p.s.) 34.72
Profit Margin (%) 15.6
Operating Margin (%) 28.7
Return on Assets (ttm) 6
Return on Equity (ttm) 11.8
Qtrly Rev. Growth 27.7
Gross Profit (p.s.) 24.24
Sales Per Share 50.75
EBITDA (p.s.) 17.36
Qtrly Earnings Growth 50
Operating Cash Flow 818 (M)
Levered Free Cash Flow 93 (M)

Stock Valuations

PE Ratio 14.85
PEG Ratio 8.3
Price to Book value 0.3
Price to Sales 0.2
Price to Cash Flow 0.56

Stock Dividends

Dividend 0
Forward Dividend 0
Dividend Yield 0%
Dividend Pay Date Invalid DateTime.
Ex-Dividend Date Invalid DateTime.
Your Ad Here
android_stock_chart
StockChart iOS
stoxline_lite
StoxlineLite iOS
stoxline_pro
StoxlineLite iOS
Option_Calculator
OptionCalc iOS
android_stock_chart
StockChart Android
stoxline_lite
StoxlineLite Android
stoxline_pro
StoxlinePro Android
Option_Calculator
OptionCalc Android
(c) 2006-2022 Stoxline.com | Contact us           
Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither Stoxline.com nor its data provider shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the Stoxline.com web site, a user agrees not to redistribute the information found therein.